Preliminary research reveal conolidine may well inhibit certain ion channels, cutting down neuronal excitability and limiting soreness signals. This mechanism is particularly applicable in neuropathic discomfort, in which irregular signaling causes persistent distress. Moreover, conolidine appears to impact G protein-coupled receptor (GPCR) pathway